Literature DB >> 23570976

Mesoscopic modeling as a starting point for computational analyses of cystic fibrosis as a systemic disease.

Eberhard O Voit1.   

Abstract

Probably the most prominent expectation associated with systems biology is the computational support of personalized medicine and predictive health. At least some of this anticipated support is envisioned in the form of disease simulators that will take hundreds of personalized biomarker data as input and allow the physician to explore and optimize possible treatment regimens on a computer before the best treatment is applied to the actual patient in a custom-tailored manner. The key prerequisites for such simulators are mathematical and computational models that not only manage the input data and implement the general physiological and pathological principles of organ systems but also integrate the myriads of details that affect their functionality to a significant degree. Obviously, the construction of such models is an overwhelming task that suggests the long-term development of hierarchical or telescopic approaches representing the physiology of organs and their diseases, first coarsely and over time with increased granularity. This article illustrates the rudiments of such a strategy in the context of cystic fibrosis (CF) of the lung. The starting point is a very simplistic, generic model of inflammation, which has been shown to capture the principles of infection, trauma, and sepsis surprisingly well. The adaptation of this model to CF contains as variables healthy and damaged cells, as well as different classes of interacting cytokines and infectious microbes that are affected by mucus formation, which is the hallmark symptom of the disease (Perez-Vilar and Boucher, 2004) [1]. The simple model represents the overall dynamics of the disease progression, including so-called acute pulmonary exacerbations, quite well, but of course does not provide much detail regarding the specific processes underlying the disease. In order to launch the next level of modeling with finer granularity, it is desirable to determine which components of the coarse model contribute most to the disease dynamics. The article introduces for this purpose the concept of module gains or ModGains, which quantify the sensitivity of key disease variables in the higher-level system. In reality, these variables represent complex modules at the next level of granularity, and the computation of ModGains therefore allows an importance ranking of variables that should be replaced with more detailed models. The "hot-swapping" of such detailed modules for former variables is greatly facilitated by the architecture and implementation of the overarching, coarse model structure, which is here formulated with methods of biochemical systems theory (BST). This article is part of a Special Issue entitled: Computational Proteomics, Systems Biology & Clinical Implications. Guest Editor: Yudong Cai.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biochemical systems theory; Cystic fibrosis; Disease simulator; Mathematical model; Systems biology

Mesh:

Year:  2013        PMID: 23570976      PMCID: PMC3770779          DOI: 10.1016/j.bbapap.2013.03.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  48 in total

1.  Models-of-data and models-of-processes in the post-genomic era.

Authors:  Eberhard O Voit
Journal:  Math Biosci       Date:  2002 Nov-Dec       Impact factor: 2.144

2.  Allometric morphogenesis of complex systems: Derivation of the basic equations from first principles.

Authors:  M A Savageau
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation.

Authors:  Angela Reynolds; Jonathan Rubin; Gilles Clermont; Judy Day; Yoram Vodovotz; G Bard Ermentrout
Journal:  J Theor Biol       Date:  2006-04-03       Impact factor: 2.691

4.  System estimation from metabolic time-series data.

Authors:  Gautam Goel; I-Chun Chou; Eberhard O Voit
Journal:  Bioinformatics       Date:  2008-09-04       Impact factor: 6.937

5.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

6.  Inflammatory cytokines in cystic fibrosis lungs.

Authors:  T L Bonfield; J R Panuska; M W Konstan; K A Hilliard; J B Hilliard; H Ghnaim; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

7.  Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.

Authors:  Rabindra Tirouvanziam; Yael Gernez; Carol K Conrad; Richard B Moss; Iris Schrijver; Colleen E Dunn; Zoe A Davies; Leonore A Herzenberg; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

Review 8.  Recent developments in parameter estimation and structure identification of biochemical and genomic systems.

Authors:  I-Chun Chou; Eberhard O Voit
Journal:  Math Biosci       Date:  2009-03-25       Impact factor: 2.144

Review 9.  Mechanistic simulations of inflammation: current state and future prospects.

Authors:  Yoram Vodovotz; Gregory Constantine; Jonathan Rubin; Marie Csete; Eberhard O Voit; Gary An
Journal:  Math Biosci       Date:  2008-08-26       Impact factor: 2.144

10.  Estimation of dynamic flux profiles from metabolic time series data.

Authors:  I-Chun Chou; Eberhard O Voit
Journal:  BMC Syst Biol       Date:  2012-07-09
View more
  5 in total

1.  Fibroblasts: Diverse Cells Critical to Biomaterials Integration.

Authors:  Riley T Hannan; Shayn M Peirce; Thomas H Barker
Journal:  ACS Biomater Sci Eng       Date:  2017-06-13

Review 2.  Computational modeling of cardiac fibroblasts and fibrosis.

Authors:  Angela C Zeigler; William J Richardson; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2015-12-01       Impact factor: 5.000

3.  ENaC regulation by phospholipids and DGK explained through mathematical modeling.

Authors:  Daniel V Olivença; Eberhard O Voit; Francisco R Pinto
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

4.  Stochastic tracking of infection in a CF lung.

Authors:  Sara Zarei; Ali Mirtar; Forest Rohwer; Peter Salamon
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

5.  A heuristic model of alcohol dependence.

Authors:  Zhen Qi; Felix Tretter; Eberhard O Voit
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.